BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 32026536)

  • 21. Exploring the impact of preoperative insulin resistance levels on outcomes after metabolic surgery: a focus on multiracial type 2 diabetes patients.
    Cao Y; Tang H; Zhu S; Zhu L
    Surg Obes Relat Dis; 2024 Feb; 20(2):214. PubMed ID: 38007351
    [No Abstract]   [Full Text] [Related]  

  • 22. Correlation analysis of microribonucleic acid-155 and microribonucleic acid-29 with type 2 diabetes mellitus, and the prediction and verification of target genes.
    Zhu J; Wang C; Zhang X; Qiu T; Ma Y; Li X; Pang H; Xiong J; Yang X; Pan C; Xie J; Zhang J
    J Diabetes Investig; 2021 Feb; 12(2):165-175. PubMed ID: 32579760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Bariatric Surgery on Plasma Cell-Free Mitochondrial DNA, Insulin Sensitivity and Metabolic Changes in Obese Patients.
    Yuzefovych LV; Pastukh VM; Mulekar MS; Ledbetter K; Richards WO; Rachek LI
    Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37760955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correction to: "Transcriptome Changes and Metabolic Outcomes After Bariatric Surgery in Adults With Obesity and Type 2 Diabetes".
    J Endocr Soc; 2024 Mar; 8(5):bvae046. PubMed ID: 38487211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Letter to the Editor: Alternative Methods for Accurately Measuring Height to Investigate BMI Changes in Obese Patients After Metabolic/Bariatric Surgery.
    Mokhber S; Rezaei M; Sadat SZ; Gholi Z
    Obes Surg; 2024 May; ():. PubMed ID: 38806845
    [No Abstract]   [Full Text] [Related]  

  • 26. Follistatin as a Potential Biomarker for Identifying Metabolically Healthy and Unhealthy Obesity: A Cross-Sectional Study.
    Erbakan AN; Mutlu HH; Uzunlulu M; Caştur L; Akbaş MM; Kaya FN; Erbakan M; İşman FK; Oğuz A
    J Pers Med; 2024 May; 14(5):. PubMed ID: 38793069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bariatric surgery, through beneficial effects on underlying mechanisms, improves cardiorenal and liver metabolic risk over an average of ten years of observation: A longitudinal and a case-control study.
    Kokkinos A; Tsilingiris D; Simati S; Stefanakis K; Angelidi AM; Tentolouris N; Anastasiou IA; Connelly MA; Alexandrou A; Mantzoros CS
    Metabolism; 2024 Mar; 152():155773. PubMed ID: 38181882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum levels of Activin A: Marker of insulin resistance and cardiovascular risk in prediabetics.
    Chauhan A; Gupta A; Goyal P; Kumar T
    J Family Med Prim Care; 2022 Oct; 11(10):5983-5989. PubMed ID: 36618207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating profile of Activin-Follistatin-Inhibin Axis in women with hypothalamic amenorrhea in response to leptin treatment.
    Bouzoni E; Perakakis N; Mantzoros CS
    Metabolism; 2020 Dec; 113():154392. PubMed ID: 33045195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease.
    Perakakis N; Stefanakis K; Mantzoros CS
    Metabolism; 2020 Oct; 111S():154320. PubMed ID: 32712221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients.
    Immonen H; Hannukainen JC; Iozzo P; Soinio M; Salminen P; Saunavaara V; Borra R; Parkkola R; Mari A; Lehtimäki T; Pham T; Laine J; Kärjä V; Pihlajamäki J; Nelimarkka L; Nuutila P
    J Hepatol; 2014 Feb; 60(2):377-83. PubMed ID: 24060855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bariatric surgery in patients with type 2 diabetes: benefits, risks, indications and perspectives.
    Scheen AJ; De Flines J; De Roover A; Paquot N
    Diabetes Metab; 2009 Dec; 35(6 Pt 2):537-43. PubMed ID: 20152741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes improvement and resolution following laparoscopic vertical sleeve gastrectomy (LVSG) versus laparoscopic Roux-en-Y gastric bypass (LRYGB) procedures: a systematic review of randomized controlled trials.
    Osland E; Yunus RM; Khan S; Memon B; Memon MA
    Surg Endosc; 2017 Apr; 31(4):1952-1963. PubMed ID: 27623997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic regulation of activins in healthy individuals and in obese patients undergoing bariatric surgery.
    Perakakis N; Kokkinos A; Peradze N; Tentolouris N; Ghaly W; Tsilingiris D; Alexandrou A; Mantzoros CS
    Diabetes Metab Res Rev; 2020 Jul; 36(5):e3297. PubMed ID: 32026536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follistatins in glucose regulation in healthy and obese individuals.
    Perakakis N; Kokkinos A; Peradze N; Tentolouris N; Ghaly W; Tsilingiris D; Alexandrou A; Mantzoros CS
    Diabetes Obes Metab; 2019 Mar; 21(3):683-690. PubMed ID: 30393997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Roux-en-Y gastric bypass on circulating follistatin, activin A, and peripheral ActRIIB signaling in humans with obesity and type 2 diabetes.
    Pham TCP; Bojsen-Møller KN; Madsbad S; Wojtaszewski JFP; Richter EA; Sylow L
    Int J Obes (Lond); 2021 Feb; 45(2):316-325. PubMed ID: 32873911
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.